首页> 外文期刊>International Journal of Clinical Medicine >The Application of Laparoscopic B-Ultrasound Microwave Ablation Technology in Liver Metastasis of Colorectal Cancer
【24h】

The Application of Laparoscopic B-Ultrasound Microwave Ablation Technology in Liver Metastasis of Colorectal Cancer

机译:腹腔镜B超微波消融技术在结直肠癌肝转移中的应用

获取原文
           

摘要

Liver is the most common metastasis target organ in the late stage of colorectal cancer. More than 50% of colorectal cancer patients will have simultaneous or heterochronous liver metastasis. The survival time of patients with colorectal cancer and liver metastasis (CRLM) is short; not all patients can get radical resection of liver metastasis. For this part of patients, microwave ablation technology has been proved to be one of the effective methods for the treatment of liver metastasis. Laparoscopic B-ultrasound ablation also highlights a lot of minimally invasive advantages; this paper reviews the relevant literature of PubMed database, Wanfang database and CNKI database, in order to provide the treatment basis for clinical application of microwave ablation technology under laparoscopic B-ultrasound in the treatment of CRLM. The results showed that the safety and effectiveness of microwave ablation for liver metastases under the location of B-ultrasonic laparoscopy were confirmed, and patients with liver metastases of colorectal cancer who could not be resected could choose this treatment.
机译:肝脏是结直肠癌后期最常见的转移靶器官。超过50%的结肠直肠癌患者将具有同时或异显性的肝转移。结肠直肠癌和肝转移(CRLM)的患者的存活时间短;并非所有患者都可以激发肝转移。对于这部分患者来说,被证明是微波消融技术是治疗肝转移的有效方法之一。腹腔镜B超声消融也强调了很多微创优势;本文介绍了PubMed数据库,WANFANG数据库和CNKI数据库的相关文献,以便为微波消融技术在腹腔镜B超处理下进行CRLM的临床应用的治疗基础。结果表明,确认了B超腹腔镜检查镜检查下肝转放酶的微波消融的安全性和有效性,并且肝脏转移患者无法切除,患者可以选择这种治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号